Navigation Links
Choose the Right Transfection Agent for Your RNAi Experiment


The success of any RNA interference experiment depends on the efficient delivery of siRNA or siRNA expression vehicles (plasmids, PCR fragments) into cells. Many researchers use cationic liposomal and polyamine based reagents to deliver these molecules into cultured mammalian cells. The choice of reagent and the conditions under which it is used depend on the type of cells and the type of molecule being transfected. Reagents optimized for delivery of plasmid DNA are not optimal for delivering siRNA, and vice versa. Furthermore, few transfection agents intended for plasmid DNA transfection work well for transfecting PCR derived siRNA expression cassettes (SECs: PCR fragments expressing siRNAs).

Ambion has performed extensive research on the reagents and conditions needed for introducing siRNA, siRNA expression plasmids, and SECs into cells. Of all of the reagents tested, two for siRNAs and one for plasmids and SECs consistently gave the best transfection efficiencies for the widest number of cell lines tested. These reagents are now provided by Ambion for transfecting mammalian cultured cells (see below).


Efficient Delivery of Plasmids and SECs -- siPORT XP-1
siPORT XP-1 is an easy-to-use reagent that efficiently delivers both plasmid DNA and PCR products into a variety of mammalian cell types. Comprised of a proprietary formulation of polyamines, the reagent exhibits low toxicity and can be used in the presence or absence of serum. siPORT XP-1 is simple to use -- reagent/DNA complexes can be added directly to growing cells in serum-containing culture media, and the media can be left unchanged until the time of assay.

An example of the plasmid transfection efficiencies that can be obtained with siPORT XP-1 is shown in Figure 1. In this figure, a plasmid designed to express -galactosidase was transfected into HeLa cells using siPORT XP-1 and the cells were analyzed by microscopy. Transfection rates of 70-80% have been achieved with HeLa cells as shown by the blue staining.

Figure 1. siPORT XP-1 Efficiently Delivers Plasmid DNA. HeLa cells were transfected with a plasmid expressing -galactosidase using siPORT XP-1. 48 hours after transfection, the cells were treated with X-gal and analyzed by microscopy. The blue color indicates -galactosidase expression.


In gene silencing experiments, high transfection efficiencies are essential in order to observe the down regulation of genes by Northern or Western analysis, or any other technique that analyzes the entire cell population, containing both transfected and nontransfected cells. In Figure 2, siPORT XP-1 was used to transfect COS-7, HeLa, and DU145 cells with a plasmid, pSilencer 2.0-U6, engineered to express an siRNA to GAPDH. Silencing effects were analyzed at the mRNA level by Northern blot 72 hours after transfection. In all three cell lines, GAPDH mRNA levels were reduced >80%, demonstrating the effectiveness of plasmid transfections by siPORT XP-1 in these three cell lines.

Figure 2. Gene Silencing in Multiple Cell Lines with an siRNA Expression Plasmid Transfected with siPORT XP-1. pSilencer 2.0-U6 was engineered to express an siRNA to GAPDH and then transfected into COS-7, HeLa, and DU145 cells with siPORT XP-1. 72 hours after transfection, RNA was isolated with the RNAqueous Kit and GAPDH mRNA levels were analyzed by Northern blot using Ambion's NorthernMax-Gly Kit. NC=no construct, ie cells transfected with transfection agent alone.


Transfecting PCR products, such as those prepared using Ambion's Silencer Express siRNA Expression Cassette Kit, can be challenging as many plasmid transfection agents are not suitable for transfection of these shorter, linear dsDNAs. However, XP-1 is also efficient at introducing SECs and other PCR products into a range of mammalian cell types. Protocols for transfecting SECs are distinct from those for transfecting plasmid expression vectors and are outlined in a separate section of the siPORT XP-1 Protocol. Figure 3 shows the use of siPORT XP-1 for transfecting SECs targeting GAPDH into five different cell lines. GAPDH mRNA levels were reduced by >90% in three of the five cell lines, and >75% in the remaining two.

Figure 3. SECs Delivered with siPORT XP-1 Induce Gene Silencing. siRNA Expression Cassettes (SECs) were prepared with the Silencer Express (Mouse U6) siRNA Expression Cassette Kit and then transfected into HepG2, COS-7, MCF-7, HeLa, and DU145 cells with siPORT XP-1. Gene silencing effects were monitored by Northern blot 72 hours after transfection. RNA was isolated with the RNAqueous Kit, and Northern blots were performed using the NorthernMax-Gly Kit (Ambion).


Transfecting siRNAs into a Broad Range of Cell Types -- siPORT Amine and siPORT Lipid
In contrast to the DNA based expression systems for siRNA described above, many researchers perform transient RNAi experiments by direct transfection of siRNAs into cells. siPORT Amine (a polyamine mixture) and siPORT Lipid (a mixture of cationic and neutral lipids) are the transfection agents of choice for introducing siRNAs into a wide variety of mammalian cultured cells (Figure 4). We have found that different cell types are preferentially transfected with one or the other transfection agent. For instance, siPORT Lipid provides higher transfection efficiencies in HeLa cells, whereas siPORT Amine gives higher transfection efficiencies in 293 cells. Both agents demonstrate low cytotoxicity and are ideal for introducing individual siRNAs prepared by chemical synthesis or in vitro transcription, as well as siRNA populations prepared by digestion of long dsRNA by RNase III or Dicer.

Figure 4. Delivery of siRNA by siPORT Lipid and siPORT Amine Induces RNAi. The indicated cell types were transfected with GAPDH siRNA or negative control siRNA using either siPORT Amine or siPORT Lipid Transfection Agent. RNA was isolated with the RNAqueous Kit and gene silencing effects were monitored by Northern blot using the NorthernMax-Gly Kit. Bars indicate gene expression levels 48 hours after delivery of the gene-specific siRNA relative to negative control wells.


Optimizing siRNA Transfection Parameters
By choosing the right transfection agent and optimizing cell density, transfection agent amount, and siRNA concentration, high levels of transfection efficiency can be achieved in many cell types. For developing an optimal siRNA transfection protocol in your experimental system, Ambion has combined the siPORT Amine and siPORT Lipid agents with a GAPDH- targeting siRNA and a negative control siRNA in the Silencer Transfection Kit. After transfection of the positive control, reduction in GAPDH activity can be monitored by immunofluorescence or Western blot with Ambion's monoclonal antibody to GAPDH, or by Northern blot, RT-PCR or RPA. Alternatively, siRNA uptake can be monitored directly by fluorescently labeling the siRNA with the Silencer siRNA Labeling Kit. For detailed information about optimizing siRNA transfection parameters, see the article "Optimize Transfection of siRNAs for RNAi".


back to top


Ordering Information
Cat# Product Name Size 1632 Silencer siRNA Labeling Kit - Cy3 65 g labeled siRNA 1634 Silencer siRNA Labeling Kit - FAM 65 g labeled siRNA 4300 anti-GAPDH, mouse monoclonal 6C5 100 g 4502 siPORT Amine Transfection Agent 0.4 ml 4503 siPORT Amine Transfection Agent 1 ml 4504 siPORT Lipid Transfection Agent 0.4 ml 4505 siPORT Lipid Transfection Agent 1 ml 4506 siPORT XP-1 Transfection Agent 0.4 ml 4507 siPORT XP-1 Transfection Agent 1 ml
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Multichannel Pipetting: How to Choose the Correct Pipettor
2. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
3. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
4. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
5. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
6. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
7. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
8. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells
9. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
10. Efficient Transfection of Neurospora Crassa
11. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Choose the Right Transfection Agent for Your RNAi Experiment

(Date:12/15/2014)... 15, 2014  Ascendis Pharma A/S, a biotechnology ... address significant unmet medical needs, today announced positive ... pediatric study to evaluate once-weekly TransCon Growth Hormone ... This interim analysis consists of 25 patients, representing ... the study, completing all six months of treatment. ...
(Date:12/13/2014)... and Virgin Unite Canada, the non-profit foundation of the Virgin ... Canadian entrepreneurs tackling social and environmental challenges. Today, Sir ... Centre to announce the new partnership, which includes the development ... $1 million in seed capital provided by Virgin Unite Canada ... Foundation, founded by Alison Lawton . ...
(Date:12/13/2014)... 12, 2014 The DNA Microarray ... 2013, and is expected to grow at a ... Browse through the TOC of the DNA Microarray ... and segments, with help of various tables and ... DNA Microarray market consists of instrument, consumables, and ...
(Date:12/13/2014)... The “Global Synthetic Biology Market (2013-2018)”, analyses and ... challenges. , The global synthetic biology market is ... Scientific, Inc. (U.S.), DuPont (U.S.), and Royal DSM ... ~65% of the total synthetic biology market. ... @ http://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html , Thermo Fisher Scientific, ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 3
... Wins for Industry Leadership, JOPLIN, Mo., Jan. ... announced its Medical Power group has received,Battery Power ... received honors in the Industry Leadership category for ... battery., The Innova Award recognizes companies that ...
... BSX ) today announced that it has completed ... to the Getinge Group of,Sweden for $750 million in ... 5, 2007., The Company expects to record after-tax ... These charges will be recorded,during the fourth quarter of ...
... VICL ) today announced that Vijay Samant, ... panel discussion on biodefense and,pandemic influenza Wednesday evening ... CA - January 7-10)., The session is ... Aldridge LLP.,Co-keynotes for the session are Rajeev Venkayya, ...
Cached Biology Technology:EaglePicher Technologies Receives Battery Power Products and Technology's First Annual Innova Award 2Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses 2Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses 3Vical to Participate in Pandemic Influenza Panel at JPMorgan Healthcare Conference 2
(Date:12/5/2014)... PROVO, Utah , Dec. 4, 2014  Tute ... has raised $2.3 million in Series A1 funding led ... angel investors also participated in the investment round. ... as the healthcare community adopts next-generation sequencing and seeks ... disease," said Reid Robison , MD MBA, and ...
(Date:12/3/2014)... 2, 2014   Marvin Test Solutions , ... solutions for military, aerospace, and manufacturing organizations, today ... successful TS-900 PXI semiconductor test platform . ... high-end systems to customers at a fraction of ... traditional ATE. "Our semiconductor customers ...
(Date:11/21/2014)... DALLAS , November 18, 2014 ... Security Systems Market by Systems (Video, RFID, Access Control, ... (SEZ, Factories, Hotels, Banks, Government), Component Service Geography - ... Security Systems Market is projected to be around $25 ... Billion by 2020, growing at a CAGR of 8.69%. ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... If pending clinical trials prove successful, a new ... http://www.fasebj.org ) could represent a major scientific leap toward ... appearing online, Yale scientists provide evidence to support a ... idea that cells added to a graft before implantation ...
... R.I. [Brown University] Aggregating nearly the entire landmass of ... not seen for the last 200 million years. Its size ... roam, for there were few geographical barriers, such as mountains ... confined themselves. Studying a transect of Pangaea stretching from about ...
... This release is available in German . ... Muscle contractions are the basis of all movements, at least ... don,t have any muscles at all, as they branched off ... animal groups, for instance the sea sponges, are not immovable. ...
Cached Biology News:Yale scientists discover new method for engineering human tissue regeneration 2Latitude and rain dictated where species lived 2Latitude and rain dictated where species lived 3Movement without muscles 2
Chicken polyclonal to QPRT ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to Internal sequence amino acids 123-237 of Human QPRT Entrez Gene ID: 23475 ...
Antibody Diluent for IHC 125 ml...
QPRT Antibody...
Mouse monoclonal [4C4] to Y14 ( Abpromise for all tested applications). entrezGeneID: 9939 SwissProtID: Q9Y5S9...
Biology Products: